DISHMAN - Dishman Pharmaceuticals & Chemicals (Amalgamated)

Dishman Pharmaceuticals & Chemicals (Amalgamated)

DISHMAN · Pharma > Pharmaceuticals & Drugs · Chairman: Janmejay R Vyas · MD: Arpit J Vyas · Listing date: April 23, 2004

Stock Price vs Company Growth

0.5%

10y

16.2%

all

5.4%

🤔 How to analyze this graph?

Last Traded Price

₹ 301 0%

N/A

301

Company Overview

Sales

1,672 Cr

Growth: 9.3%

Profit after Tax

161 Cr

Growth: -9.7%

Small Cap

4,861 Cr

P/E: 30.2x

Industry P/E: 36.7x

Fundamentals

Sales (Cr)	₹ 1,672
Growth	9.3%
EBITDA	25.6%
P/S	2.9x
Dividend	0.0%
P/E	30.2x
Book Value	₹ 99.4
PEG Ratio	3.2x
ROE	10.3%
P/B	3.0x

Shareholding Pattern

Institutions

L And T Mutual Fund Trustee Ltd-L And T India Prudence Fund

4.39 %

Birla Sun Life Trustee Company Private Limited A/C Birla Sun Life Equity Fund

2.27 %

Tata Balanced Fund

1.88 %

Lsv Emerging Markets Equity Fund Lp

1.45 %

Promoters

Bhadra Raj Holdings Private Limited

61.4 %

Others

Increase Decrease No change

Company Profile Detailed

Dishman Pharmaceuticals and Chemicals Limited (DPCL) was incorporated in 1983 as a research-oriented company. Later in 1989 the company started production of a range of phase transfer catalysts and quaternary ammonium and phosphonium compounds. The company became a global market leader and earned the status of the “Quat Company”. In the period of 10 years the production capacity was increased from 10MT per annum to 1500 Mt per annum.